Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine Cardiovascular Outcomes Trial (COLCOT)
2014-005172-28Phase 3Completed
- Sponsor
- Montréal Heart Institute
- Start
- Nov 2015
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in myocardial infarction (MI) and coronary arteriosclerosis comparing Colchicine with Placebo (2 arms). Primary endpoint: Primary composite cardiovascular endpoint. Started Nov 2015; status: completed.
02
Drugs
colchicine
03
Conditions
myocardial infarction (MI)coronary arteriosclerosis
Beyond the preview
Go deeper on 2014-005172-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005172-28.